Monte Rosa Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $269k | 36k | 7.41 |
| 2025-06-30 | $152k | 34k | 4.51 |
| 2025-03-31 | $133k | 29k | 4.64 |
| 2024-12-31 | $487k | 70k | 6.94 |
| 2024-09-30 | $118k | 22k | 5.30 |
| 2024-06-30 | $61k | 16k | 3.74 |
| 2024-03-31 | $93k | 13k | 7.05 |
| 2023-12-31 | $67k | 12k | 5.65 |
| 2023-09-30 | $47k | 9.8k | 4.79 |
| 2023-06-30 | $94k | 14k | 6.85 |
| 2022-09-30 | $1.0k | 80 | 12.50 |
| 2022-06-30 | $2.0k | 253 | 7.91 |
| 2022-03-31 | $221k | 16k | 14.04 |
| 2021-12-31 | $322k | 16k | 20.41 |
| 2021-09-30 | $1.0k | 57 | 17.54 |